Unconventional therapies for cancer: 2. Green tea

CMAJ. Canadian Medical Association Journal

Volumn 158, Issue 8, 1998, Pages 1033-1035

  Kaegi, Elizabeth ^a   Schneider, Marilyn ^b  

^a Societe canadienne du cancer   (Canada)

^b Can Breast Cancer Res Initiative   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; EPIGALLOCATECHIN GALLATE;

CANCER; CANCER PREVENTION; DRINKING BEHAVIOR; DRUG MECHANISM; DRUG SAFETY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MEDICINAL PLANT; NONHUMAN; ORAL DRUG ADMINISTRATION; SHORT SURVEY; TEA; TUMOR GROWTH;

EID: 0032554703     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. Chow K, Kramer I. All the tea in China. San Francisco: China Books and Periodicals; 1990.
2. Tea Council of Canada. Tea cunsumption and related health benefits. Toronto: The Council; Spring 1994.
3. Kapadia GJ, Paul BD, Chung EB, Ghosh B, Pradhan SN. Carcinogenicity of Camellia sinensis (tea) and some tannin-containing folk medicinal herbs administered subcutaneously in rats. J Natl Cancer Inst 1976;57(1):207-9.
4. Nagao M, Takahashi Y, Yamanaka H, Sugimura T. Mutagens in coffee and tea. Mutat Res 1979;68:101-6.
5. Kinlen LJ, Willows AN, Goldblatt P, Yudkin J. Tea consumption and cancer. Br J Cancer 1988;58(3):397-401.
6. Tewes FJ, Koo LC, Meisgen TJ, Rylander R. Lung cancer risk and mutagenicity of tea. Environ Res 1990;52(1):23-33.
7. Tea [review]. IARC Monogr Eval Carcinog Risks Hum 1991;51:207-71.
8. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF Jr. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 1994;86(11):855-8.
9. Weisburger JH. Introduction: physiological and pharmacological effects of Camellia sinensis (tea): first international symposium. Prev Med 1992;21:329-30.
10. Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 1993;85(13):1038-49.
11. Jain AK, Shimoi K, Nakamura Y, Kada T, Hara Y, Tomita I. Crude tea extracts decrease the mutagenic activity of N-methyl-N′-nitro-N-nitrosoguanidine in vitro and in intragastric tract of rats. Mutat Res 1989;210:1-8.
12. Ito Y, Ohnishi S, Fujie K. Chromosome aberrations induced by aflatoxin B1 in rat bone marrow cells in vivo and their suppression by green tea. Mutat Res 1989;222:253-61.
13. Wang ZY, Cheng SJ, Zhou ZC, Athar M, Khan WA, Bickers DR, et al. Antimutagenic activity of green tea polyphenols. Mutat Res 1989;223:273-85.
14. Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan-Olive T, Lou YR, et al. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 1992;13(6):947-54.
15. Oguni I, Nasu K, Yamamoto S, Nomura T. On the antitumor activity of fresh green tea leaf. Agric Biol Chem 1988;52(7):1879-80.
16. Wang ZY, Huang MT, Ho CT, Chang R, Ma W, Ferraro T, et al. Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 1992;52:6657-65.
17. Taniguchi S, Fujiki H, Kobayashi H, Go H, Miyado K, Sadano H, et al. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 1992;65:51-4.
18. Sazuka M, Murakami S, Isemura M, Satoh K, Nukiwa T. Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett 1995;98:27-31.
19. Okuda T, Mori K, Hayatsu H. Inhibitory effect of tannins on direct-acting mutagens. Chem Pharm Bull (Tokyo) 1984;32(9):3755-8.
20. Kada T, Kaneko K, Matsuzaki S, Matsuzaki T, Hara Y. Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor. Mutat Res 1985;150:127-32.
21. Ruch RJ, Cheng SJ, Klaunig JE. Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis 1989;10(6):1003-8.
22. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-50.
23. Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 1995;96:239-43.
24. Sakagami H, Asano K, Hara V, Shimamura T. Stimulation of human monocyte and polymorphonuclear cell iodination and interleukin-1 production by epigallocatechin gallate. J Leukoc Biol 1992;51:478-83.
25. Sakagami H, Takeda M, Sugaya K, Omata T, Takahashi H, Yamamura M, et al. Stimulation by epigallocatechin gallate of interleukin-1 production by human peripheral blood mononuclear cells. Anticancer Res 1995;15:971-4.
26. Hu ZQ, Toda M, Okubo S, Hara Y, Shimamura T. Mitogenic activity of (-)epigallocatechin gallate on B-cells and investigation of its structure-function relationship. Int J Immunopharmacol 1992;14(8):1399-407.
27. Isemura M, Suzuki Y, Satoh K, Narumi K, Motomiya M. Effects of catechins on the mouse lung carcinoma cell adhesion to endothelial cells. Cell Biol Int 1993;17(6):559-64.
28. Nakagami T, Nanaumi-Tamura N, Toyomura K, Nakamura T, Shigehisa T. Dietary flavonoids as potential natural biological response modifiers affecting the autoimmune system. J Food Sci 1995;60(4):653-6.